ES2136093T3 - Fomentacion que contiene cetorolac. - Google Patents

Fomentacion que contiene cetorolac.

Info

Publication number
ES2136093T3
ES2136093T3 ES92922993T ES92922993T ES2136093T3 ES 2136093 T3 ES2136093 T3 ES 2136093T3 ES 92922993 T ES92922993 T ES 92922993T ES 92922993 T ES92922993 T ES 92922993T ES 2136093 T3 ES2136093 T3 ES 2136093T3
Authority
ES
Spain
Prior art keywords
cetorolac
water
promotion containing
promotion
humectant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92922993T
Other languages
English (en)
Inventor
Kanji Noda
Masaru Saita
Munehiko Hirano
Yasuhiro Ikeura
Yasuaki Taniguchi
Terushi Hashiguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2136093T3 publication Critical patent/ES2136093T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Confectionery (AREA)

Abstract

UN FOMENTO QUE CONTIENE CETOROLAC, UNO DE LOS ANALGESICOS ANTIINFLAMATORIOS NO ESTEROIDES, O UNA SAL DEL MISMO COMO INGREDIENTE ACTIVO, UN COMPUESTO DE ALTO PESO MOLECULAR SOLUBLE EN AGUA COMO INGREDIENTE BASE, UN HUMECTANTE, AGUA Y OPCIONALMENTE UN PROMOTOR DE LA ABSORCION.
ES92922993T 1991-11-11 1992-11-06 Fomentacion que contiene cetorolac. Expired - Lifetime ES2136093T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32364791 1991-11-11

Publications (1)

Publication Number Publication Date
ES2136093T3 true ES2136093T3 (es) 1999-11-16

Family

ID=18157054

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92922993T Expired - Lifetime ES2136093T3 (es) 1991-11-11 1992-11-06 Fomentacion que contiene cetorolac.

Country Status (13)

Country Link
US (1) US5519046A (es)
EP (1) EP0612521B1 (es)
JP (1) JP2902113B2 (es)
KR (1) KR0140155B1 (es)
AT (1) ATE181667T1 (es)
AU (1) AU669492B2 (es)
CA (1) CA2123109A1 (es)
DE (1) DE69229506T2 (es)
DK (1) DK0612521T3 (es)
ES (1) ES2136093T3 (es)
GR (1) GR3031346T3 (es)
TW (1) TW360544B (es)
WO (1) WO1993009768A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
CA2200068C (en) * 1994-09-16 2005-01-11 Munehiko Hirano A preparation for external use and a patch having the preparation attached thereto
US6620430B2 (en) * 1996-12-06 2003-09-16 Hisamitsu Pharmaceutical Co., Inc. Plaster containing felbinac
US6730323B1 (en) * 1996-12-18 2004-05-04 Care Teck Laboratories, Inc. Microclysmic gel for treatment of tissue trauma and burns
DE69927154T2 (de) * 1998-06-25 2006-06-29 Lavipharm Laboratories, Inc. Vorrichtung und verfahren zur behandlung von erektionsstörungen
EP1170006B8 (en) * 1999-12-14 2008-03-19 Teikoku Seiyaku Co., Ltd. Drug for alleviating migraine
EP1128285B1 (en) * 2000-02-21 2010-04-28 Hewlett-Packard Company, A Delaware Corporation Augmentation of sets of image recordings
KR20020037616A (ko) * 2000-11-15 2002-05-22 서경배 케토롤락의 경피흡수제제
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US20030198616A1 (en) * 2002-04-23 2003-10-23 Combe Incorporated Moisturizing skin gel and method
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
WO2005101982A2 (en) * 2004-03-24 2005-11-03 Sun Pharmaceutical Industries Limited A stable ophthalmic composition
JP2008542308A (ja) * 2005-06-02 2008-11-27 タリオン ファーマシューティカルズ インク． ファルネシルジベンゾジアゼピノン製剤
ES2557475T3 (es) * 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
BRPI0504797B1 (pt) * 2005-10-27 2020-02-04 Pele Nova Biotecnologia S A formulação tópica, método de tratamento cosmético para rejuvenescimento da pele, método de tratamento cosmético e uso de uma formulação
WO2009087658A2 (en) * 2007-11-07 2009-07-16 Sun Pharma Advanced Research Company Limited Composition suitable for parenteral administration
JP5606683B2 (ja) * 2009-02-25 2014-10-15 帝國製薬株式会社 ケトロラックの経皮吸収用組成物
CN101957667B (zh) * 2009-07-17 2012-09-05 致伸科技股份有限公司 可置换脚垫的鼠标
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINO-QUINOLINES AS KINASE INHIBITORS
RU2500399C2 (ru) * 2012-02-17 2013-12-10 Общество с ограниченной ответственностью "ФармЭталон" Комбинированное анальгезирующее и спазмолитическое средство
JP6104222B2 (ja) * 2014-10-28 2017-03-29 帝國製薬株式会社 非ステロイド系消炎鎮痛貼付剤
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
JPS539788A (en) * 1976-07-14 1978-01-28 Syntex Inc 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
JPS6254109A (ja) 1985-03-28 1987-03-09 Sumitomo Metal Ind Ltd 帯状体の巾・蛇行測定装置
JPH07112984B2 (ja) * 1989-04-28 1995-12-06 久光製薬株式会社 泡状エアゾール製剤
US5478567A (en) * 1991-08-30 1995-12-26 Hisamitsu Pharmaceutical Co., Inc. Antiphlogistic analgesic plaster
JP3477211B2 (ja) * 1992-05-22 2003-12-10 久光製薬株式会社 ケトロラック含有リザーバー型貼付剤

Also Published As

Publication number Publication date
DE69229506D1 (de) 1999-08-05
JP2902113B2 (ja) 1999-06-07
CA2123109A1 (en) 1993-05-27
EP0612521A4 (en) 1995-06-07
EP0612521B1 (en) 1999-06-30
AU669492B2 (en) 1996-06-13
US5519046A (en) 1996-05-21
DK0612521T3 (da) 2000-01-17
DE69229506T2 (de) 1999-10-28
ATE181667T1 (de) 1999-07-15
WO1993009768A1 (en) 1993-05-27
AU2907292A (en) 1993-06-15
TW360544B (en) 1999-06-11
EP0612521A1 (en) 1994-08-31
GR3031346T3 (en) 1999-12-31
KR0140155B1 (en) 1998-06-01

Similar Documents

Publication Publication Date Title
ES2136093T3 (es) Fomentacion que contiene cetorolac.
ES2127397T3 (es) Sulfonamidas y sus derivados que modulan la actividad de la endotelina.
ES2033311T3 (es) Composicion de resina absorbente de agua.
LU91173I2 (fr) Ximelagatran, et les sels pharmaceutiquement acceptables de celui-ci (exanta).
FR2685869B1 (fr) Compositions therapeutiques a base d'inhibiteurs mixtes de la no synthase et de la cyclooxygenase.
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
ATE174492T1 (de) Chirurgisches schneidinstrument
DE68901390D1 (de) Orale zusammensetzung gegen zahnstein.
DE69323762D1 (de) Lasermarkierungsgerät
MX9204875A (es) Medicamentos para el tratamiento de reacciones de rechazo en el caso de transplantes de organos
DE69220655D1 (de) Beschichtung mit niedriger Emittierung
FR2681151B1 (fr) Generateur d'impulsions lumineuses de forte puissance.
FR2785687B1 (fr) Dispositif d'irradiation lumineuse
MX9202656A (es) Compuestos de tiadiazabiciclooctano o tiadiazabicicloocteno, procedimiento para su obtencion y composicion herbicida que los contiene.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
ATE359997T1 (de) Guanidinomethylcyclohexancarbonsäure-ester derivate
MX9200468A (es) Derivados de priemidinil- y triazinilsalicil- y picolinilaldehido, procedimiento para su preparacion y composicion herbicida que los contiene
AU1042888A (en) Pain-killer
FR2708689B1 (fr) Dispositif d'absorption d'énergie axiale.
ES2037021T3 (es) Procedimiento para la obtencion de 1,4-ciclohexanodiaminas y su empleo de fungicidas.
NO172658C (no) Fralandsplattform
KR920021152U (ko) 향기 발산 테이프
ES1013311Y (es) Fosa perfeccionada para todo tipo de aguas.
FR2701219B1 (fr) Dispositif permettant d'absorber et de retenir la totalité de la solution obtenue par un absorbeur d'humidité.
ES1018423Y (es) "carcasa perfeccionada para aparatos de iluminacion"

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 612521

Country of ref document: ES